ContactPrint • DisclaimerTerms & Conditions

Recent Publications

News

  • Cappable-seq Service now available !

    In close cooperation with New England Biolabs, Inc. (NEB), VERTIS is now able to make the new Cappable-seq method available to its customers. The method was developed by Laurence Ettwiller and Ira Schildkraut from NEB (Ettwiller, L. et al. 2016. BMC Genomics. 17, 1 (2016), 199).

    It represents the current most sensitive and robust method for the precise identification of bacterial transcription start sites (TSSs).

vertis Biotechnologie AG
Lise-Meitner-Str. 30
D-85354 Freising
Germany

Fon +49-(0)8161-18516-11
Fax +49-(0)8161-18516-12

Contact FormHow to find us

Company Profile

Established in 2000, vertis Biotechnologie AG is a privately held company with its core competence in the field of functional genomics. It was founded as a spin-off of the Technische Universität München-Weihenstephan.

Our mission is to bring the most efficient state-of-the-art tools for analysis of the transcriptomes to the worldwide biotech community. The strength of our service is customer-oriented flexibility which is based on our innovative technology platform which we have developed in our 16-year history. It is subjected to a continuous process of further improvement and optimization and is examined in co-operations with research institutions as well as with pharmaceutical and biotech companies.

All our products and services come with excellent technical support, friendly customer service and fast delivery

 

Weihenstephan

 

Publications


Career